Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological ... read more Featured Products: More products

Download Mobile App





Illumina Introduces Its Most Powerful and Sustainable Sequencer Yet at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 06 Feb 2023

Illumina Inc. More...

(San Diego, CA, USA) is introducing the NovaSeq X Plus, its most powerful and most sustainable sequencer yet, at the 22nd edition of Medlab Middle East Congress which is taking place live, in-person from 6-9 February 2023.

The NovaSeq X Plus system is the most powerful and most sustainable sequencer from Illumina and enables laboratories to complete their most ambitious ultra-high-throughput projects. Labs can scale their studies with three flow cell types and up to 16 Tb output per run on the dual flow cell NovaSeq X Plus system or up to 8 Tb on the single flow cell NovaSeq X system. Ultra-high-density flow cells and ultra-high-resolution optics enable output of up to 26 billion single reads per flow cell. XLEAP-SBS chemistry delivers the highest level of data accuracy and performance, and the increased stability enables remarkable sustainability benefits. The DRAGEN Bio-IT Platform, available onboard or in the cloud, provides award-winning accuracy for rapid, easy-to-use, and efficient genomic data analysis.

At Medlab Middle East 2023, Illumina is also demonstrating the NextSeq 1000 and NextSeq 2000 sequencing platforms that are redesigned from the ground up. Their flexibility, affordability, and scalability help both new and experienced users achieve fast turnaround times and reduced operating costs. With the wide range of available flow cells, they support a variety of applications including single-cell gene expression, special transcriptomics, whole-exome sequencing, total RNA sequencing, shotgun metagenomics and infectious disease testing.

Additionally, Illumina is holding a half-day workshop on Genomics for Rare Diseases in the Middle East, featuring the latest findings related to the genomic basis of rare diseases and providing powerful insights into disease mechanisms and therapeutic approaches. As genomic sequencing becomes more available in the hospital setting, the expert panel discussion will be examining standardization, drivers & local challenges to implementation of genomic sequencing and how this is changing clinical practice. The program consists of scientific presentations from top experts in rare diseases, diagnostics and targeted testing followed by Q&A sessions. Guest speakers will be joining panel discussion with Illumina experts to identify the research, regulatory and access policy drivers to enable integration of whole genome sequencing into a healthcare setting.

Related Links:
Illumina Inc.


New
Gold Member
Hybrid Pipette
SWITCH
Collection and Transport System
PurSafe Plus®
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more

Industry

view channel
Image: The partnership between OGT and QIAGEN unlocks a complete sample to report workflow for SureSeq NGS panels (Photo courtesy of OGT)

Qiagen and Oxford Gene Technology Partner on Sequencing Panel Interpretation

In clinical research, next-generation sequencing (NGS) panels provide essential insights for genetic analysis, but many laboratories face challenges in transforming raw sequencing data into clinically... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.